Benitec Biopharma (BNTC) Change in Account Payables (2019 - 2025)

Benitec Biopharma has reported Change in Account Payables for 7 years, with the latest figure at $701000.0 in Q4 2025.

• Quarterly Change in Account Payables fell 46.16% year-over-year to $701000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.5 million (down 1283.18% YoY) and the FY2025 annual result came in at -$2.4 million, down 352.71% from the prior year.
• Change in Account Payables grew to $701000.0 in Q4 2025 per BNTC's latest filing, from $125000.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $1.6 million in Q1 2021 and troughed at -$3.8 million in Q1 2025.
• A 5-year average of $115900.0 and a median of $533000.0 in 2022 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2021 and 2024: Change in Account Payables jumped 376.95% in 2021, then plunged 466.51% in 2024.
• Over 5 years, Change in Account Payables stood at $853000.0 in 2021, then sank by 164.48% to -$550000.0 in 2022, then surged by 307.45% to $1.1 million in 2023, then increased by 14.11% to $1.3 million in 2024, then sank by 46.16% to $701000.0 in 2025.
• According to Business Quant data, Change in Account Payables over the past three periods registered $701000.0, $125000.0, and $484000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.